Deciphera Announces Publication of the INVICTUS Pivotal Phase 3 Study of QINLOCK™ (ripretinib) in The Lancet Oncology - SC Read more about Deciphera Announces Publication of the INVICTUS Pivotal Phase 3 Study of QINLOCK™ (ripretinib) in The Lancet Oncology - SC
再鼎医药合作伙伴MacroGenics公司宣布美国FDA授予Margetuximab孤儿药认证，用于治疗胃癌 Read more about 再鼎医药合作伙伴MacroGenics公司宣布美国FDA授予Margetuximab孤儿药认证，用于治疗胃癌
Deciphera Pharmaceuticals Announces Presentations of Positive Patient Reported Outcomes Results from INVICTUS Phase 3 Study of QINLOCKTM (ripretinib) in Patients with Fourth-Line Advanced GIST at the ASCO 2020 Virtual Scientific Program - SC Read more about Deciphera Pharmaceuticals Announces Presentations of Positive Patient Reported Outcomes Results from INVICTUS Phase 3 Study of QINLOCKTM (ripretinib) in Patients with Fourth-Line Advanced GIST at the ASCO 2020 Virtual Scientific Program - SC
再鼎医药合作伙伴Deciphera公司新药Ripretinib获FDA批准用于四线胃肠道间质瘤(GIST)治疗 Read more about 再鼎医药合作伙伴Deciphera公司新药Ripretinib获FDA批准用于四线胃肠道间质瘤(GIST)治疗
FDA批准Zejula（尼拉帕利）作为唯一每日一次的PARP抑制剂单药用于含铂化疗缓解的晚期卵巢癌患者的一线维持治疗，不论其生物标志物状态如何 Read more about FDA批准Zejula（尼拉帕利）作为唯一每日一次的PARP抑制剂单药用于含铂化疗缓解的晚期卵巢癌患者的一线维持治疗，不论其生物标志物状态如何
Novocure Announces Presentation of EF-19 Post-approval Registry Trial Data Studying Optune as a Monotherapy for the Treatment of Recurrent GBM at the American Association for Cancer Research 2020 Virtual Annual Meeting I - SC Read more about Novocure Announces Presentation of EF-19 Post-approval Registry Trial Data Studying Optune as a Monotherapy for the Treatment of Recurrent GBM at the American Association for Cancer Research 2020 Virtual Annual Meeting I - SC
Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance of New Drug Application and Priority Review for Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors - SC Read more about Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance of New Drug Application and Priority Review for Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors - SC
MacroGenics宣布已向美国FDA提交Margetuximab的生物制品上市申请 Read more about MacroGenics宣布已向美国FDA提交Margetuximab的生物制品上市申请
Deciphera Pharmaceuticals宣布已向美国FDA提交Ripretinib用于治疗晚期胃肠道间质瘤患者的新药上市申请 Read more about Deciphera Pharmaceuticals宣布已向美国FDA提交Ripretinib用于治疗晚期胃肠道间质瘤患者的新药上市申请